162 related articles for article (PubMed ID: 9873466)
41. Synthesis of cryptophycins via an N-acyl-beta-lactam macrolactonization.
Vidya R; Eggen M; Nair SK; Georg GI; Himes RH
J Org Chem; 2003 Dec; 68(25):9687-93. PubMed ID: 14656095
[TBL] [Abstract][Full Text] [Related]
42. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J
Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949
[TBL] [Abstract][Full Text] [Related]
44. Antimitotic peptides and depsipeptides.
Hamel E; Covell DG
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):19-53. PubMed ID: 12678750
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and anti-tubulin activity of ustiloxin D derivatives.
Morisaki N; Mitsui Y; Yamashita Y; Koiso Y; Shirai R; Hashimoto Y; Iwasaki S
J Antibiot (Tokyo); 1998 Apr; 51(4):423-7. PubMed ID: 9630864
[TBL] [Abstract][Full Text] [Related]
46. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV
Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137
[TBL] [Abstract][Full Text] [Related]
47. The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog.
Mooberry SL; Leal RM; Tinley TL; Luesch H; Moore RE; Corbett TH
Int J Cancer; 2003 Apr; 104(4):512-21. PubMed ID: 12584751
[TBL] [Abstract][Full Text] [Related]
48. Anticancer therapy with novel tubulin-interacting drugs.
Kavallaris M; Verrills NM; Hill BT
Drug Resist Updat; 2001 Dec; 4(6):392-401. PubMed ID: 12030786
[TBL] [Abstract][Full Text] [Related]
49. A synthetic dolastatin 10 analogue suppresses microtubule dynamics, inhibits cell proliferation, and induces apoptotic cell death.
Gajula PK; Asthana J; Panda D; Chakraborty TK
J Med Chem; 2013 Mar; 56(6):2235-45. PubMed ID: 23445405
[TBL] [Abstract][Full Text] [Related]
50. Antitumor Agents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents.
Xia Y; Yang ZY; Xia P; Hackl T; Hamel E; Mauger A; Wu JH; Lee KH
J Med Chem; 2001 Nov; 44(23):3932-6. PubMed ID: 11689079
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities.
Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA
Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068
[TBL] [Abstract][Full Text] [Related]
52. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
53. [Progress in the study of tubulin inhibitors].
Shang H; Pan L; Yang S; Chen H; Cheng MS
Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562
[TBL] [Abstract][Full Text] [Related]
54. Improved total synthesis and structure-activity relationship of arenastatin A, a potent cytotoxic spongean depsipeptide.
Kobayashi M; Wang W; Ohyabu N; Kurosu M; Kitagawa I
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1598-600. PubMed ID: 7586087
[TBL] [Abstract][Full Text] [Related]
55. Design, Synthesis, and Biological Activity of Isosyringolin A.
Kitahata S; Chiba T; Yoshida T; Ri M; Iida S; Matsuda A; Ichikawa S
Org Lett; 2016 May; 18(9):2312-5. PubMed ID: 27123978
[TBL] [Abstract][Full Text] [Related]
56. Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: synthesis, stereochemistry, and NMR line broadening.
Bai R; Bates RB; Hamel E; Moore RE; Nakkiew P; Pettit GR; Sufi BA
J Nat Prod; 2002 Dec; 65(12):1824-9. PubMed ID: 12502322
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and evaluation of microtubule assembly inhibition and cytotoxicity of prenylated derivatives of cyclo-L-Trp-L-Pro.
Sanz-Cervera JF; Stocking EM; Usui T; Osada H; Williams RM
Bioorg Med Chem; 2000 Oct; 8(10):2407-15. PubMed ID: 11058035
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.
Liou JP; Chang CW; Song JS; Yang YN; Yeh CF; Tseng HY; Lo YK; Chang YL; Chang CM; Hsieh HP
J Med Chem; 2002 Jun; 45(12):2556-62. PubMed ID: 12036364
[TBL] [Abstract][Full Text] [Related]
59. Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.
Marco JA; García-Pla J; Carda M; Murga J; Falomir E; Trigili C; Notararigo S; Díaz JF; Barasoain I
Eur J Med Chem; 2011 May; 46(5):1630-7. PubMed ID: 21396747
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
